Is the product safe for consumption?

Yes, it has low toxicity and self-limited oral absorption with no known toxic syndrome.

What are the lead times for orders?

Peak season lead time is one month, while off-season is within 15 workdays.

Haematococcus Pluvialis Extract Astaxanthin 5% Powder

Name: Haematococcus Pluvialis Extract Astaxanthin 5% Powder
Brand: QINGDAO HILDA-JINGYI TRADING CO., LTD.
SKU: 1950116932

Shandong, ChinaQINGDAO HILDA-JINGYI TRADING CO., LTD.

US$1.00-100.00

1 kg

Sample price:US$300.00/piece.Request sample

Product profile

Customization

Available

Certification

BRC, ISO, HACCP

Assay Method

HPLC, UV

Application Form

Capsule, Powder, Oil

Application

Food, Health Care Products, Medicine

State

Powder

Transport Package

25kgs/Drum, Customized

Specification

1%, 1.5%, 2%, 2.5%, 3%, 3.5%, 5%, 10% UV/HPLC

Trademark

HDJY

Origin

Shannxi

Production Capacity

1000tons

Key features

Multiple Concentration Options: Available in 1%, 1.5%, 2%, 2.5%, 3%, 3.5%, 5%, and 10% concentrations.

High Purity Verification: Assayed using HPLC and UV methods for accurate potency.

Global Safety Certifications: Certified by BRC, ISO, and HACCP standards.

Potent Antioxidant Activity: Removes nitrogen dioxide, sulfide, and disulfide while inhibiting lipid peroxidation.

Versatile Application Forms: Suitable for Capsule, Powder, and Oil formulations.

Broad Industry Usage: Applied in Food, Health Care Products, Medicine, Cosmetics, and Aquaculture.

Natural Source Extraction: Derived from Haematococcus Pluvialis, a freshwater unicellular algae.

Low Toxicity Profile: Orally administered with self-limited absorption and no known toxic syndrome.

Company profile

QINGDAO HILDA-JINGYI TRADING CO., LTD.

Shandong, China

Business Type: Manufacturer/Factory, Trading CompanyExport Year: 2012-06-02Nearest Port: QINGDAO, TIANJIN,SHANGHAI,DALIAN,XIAMENAverage Response Time: ≤8.40hTerms of Payment: LC, T/T, D/P, etc.International Commercial Terms(Incoterms): FOB, CFR, CIF, DAP, CIP, FCA, EXW

AI-Powered supplier vetting

SummaryQINGDAO HILDA-JINGYI TRADING CO., LTD. is a China-based limited company in Qingdao, Shandong, described as both a trading company and manufacturer/factory. It reports more than 10 production lines, substantial stated output across seaweed, spirulina, and chlorella products, and exports to multiple global regions, with exports representing 90% of sales. The supplier lists BRC, ISO 9001, ISO 22000, GMP, and HACCP management certifications, while some certifications are attributed to joint manufacturers rather than clearly to the supplier itself. Six to ten R&D engineers and six to ten quality-control staff are reported. Evidence is insufficient to confirm after-sales service processes, customization capability, or robust customer cases. Financial credibility cannot be assessed from the permitted non-financial evidence.

Supplier typeThe supplier is identified as a China-based limited company in Qingdao and is described as both a trading company and manufacturer/factory. However, another slice categorizes the company as a trade company, so its own manufacturing role versus its trading or partner-manufacturer role is not fully clear.

CertificationsThe supplier lists BRC, ISO 9001, ISO 22000, GMP, and HACCP management-system certifications. However, the description says many joint manufacturers passed several certifications, so the evidence does not consistently establish that every certification is held directly by the supplier.

R&D capabilityThe supplier reports six to ten R&D engineers and offers products including algae extracts such as chlorella extract and phycocyanin, indicating some product-development capacity. No specific R&D projects, patents, new-product results, or technical achievements are stated.

Production capacityThe supplier reports more than 10 production lines and stated annual capacities of 10,000 tons of dried laminaria, 2,000 tons of frozen wakame, 5,000 tons of sushi nori, 1,000 tons of spirulina, and 400 tons of chlorella. Its dual trading/manufacturer description and references to joint manufacturers mean the extent of directly controlled production is not fully verified, but the reported capacity is substantial.